International Journal of Medical Research & Health Sciences
  • Year: 2018
  • Volume: 7
  • Issue: 4

A Pharmacoepidemiological Study of Cardiovascular Drugs in Intensive Cardiac Care Unit Patients in a Tertiary Care Hospital

  • Author:
  • Madiha Nooreen1,, Maryam1, Hafsah Hani1, Shaia Fatima, Hafsa Sania1, Ayesha Habeeb1, Saima Aziz2
  • Total Page Count: 6
  • Page Number: 88 to 93

1Department of Pharmacy Practice, Deccan School of Pharmacy, Telangana, India

2Department of Physiology, Ayaan Institute of Medical Sciences, Telangana, India

*Corresponding e-mail: madihanooreen94@gmail.com

Online published on 19 November, 2018.

Abstract

A cardiovascular disease increases the burden of mortality and morbidity across the globe. The aim of the study was to assess and evaluate the prescribing pattern of the cardiovascular drugs among the patients admitted in the intensive care unit of Department of Cardiology of a tertiary care hospital.

It is a single centered, observational, non-interventional, prospective study which has been carried out in a tertiary care hospital of Hyderabad, Princess Esra Hospital for a period of 6 months. The data was collected in the specifically designed form. Total 70 study sample was collected and analyzed in terms of descriptive and inferential analysis. The continuous variables were presented as mean ± SD and categorical variables were presented as numbers. Statistical analysis was done using graph pad version 7.03.

The percentage of male (51%) patients were slightly higher than females (49%). Most of the patients were in the age group of 51 to 60 years. Atorvastatin (82.85%) were found to be the most highly prescribed drug and the fixed drug combination of aspirin and clopidogrel (72.85%) was present in most of the prescriptions.

The drugs were found to be prescribed according to the current guidelines. This study analyzes the present prescribing trends of the cardiovascular drugs in the clinical scenario. The study has found that majority of the drugs prescribed were in alliance with the current guidelines. In addition to the proper prescription auditing, patients should be educated regarding the modifiable and non-modifiable risk factors causing cardiovascular diseases.

Keywords

Cardiovascular drugs, Statins, Anti-angina agents, Anti-coagulants, Diuretics, Coronary artery disease